Introduction to Physical Oncology
portes grátis
Introduction to Physical Oncology
How Mechanistic Mathematical Modeling Can Improve Cancer Therapy Outcomes
Cristini, Vittorio; Koay, Eugene; Wang, Zhihui
Taylor & Francis Ltd
12/2021
204
Mole
Inglês
9781032242798
15 a 20 dias
380
Descrição não disponível.
What Should Be Modeled in Cancer: Milestones for Physical Models. Developing More Successful Cancer Treatments with Physical Oncology. Mathematical Pathology. Mathematical Modeling of Drug Response. Prediction of Chemotherapy Outcome in Patients. Clinical Management of Pancreatic Cancer. Application of Cancer Physics in the Clinic. Tumor Morphological Behavior and Treatment Outcome. Mechanistic Model of Tumor Response to Immunotherapy. Perspectives on Physical Oncology and Future Directions
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
PDAC Tumor;PDAC;Resectable PDAC;MD Anderson Cancer Center;Physical Oncology;PLoS Comput;Tumor Kill;Monolayer Experiments;Immune Checkpoint;Drug Sensitive Cell Line;PDAC Cell;Multiple Cancer Types;Drug Delivery;ABM;Pancreatic Cancer;Normalize AUC;Immune Cell Killing;Immune Checkpoint Inhibitors;Mass Transport Properties;Immunotherapy Modeling;Free DOX;Delta Measurement;Immune Cell Recruitment;Mathematical Pathology;Non-muscle Invasive Bladder Cancer
What Should Be Modeled in Cancer: Milestones for Physical Models. Developing More Successful Cancer Treatments with Physical Oncology. Mathematical Pathology. Mathematical Modeling of Drug Response. Prediction of Chemotherapy Outcome in Patients. Clinical Management of Pancreatic Cancer. Application of Cancer Physics in the Clinic. Tumor Morphological Behavior and Treatment Outcome. Mechanistic Model of Tumor Response to Immunotherapy. Perspectives on Physical Oncology and Future Directions
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
PDAC Tumor;PDAC;Resectable PDAC;MD Anderson Cancer Center;Physical Oncology;PLoS Comput;Tumor Kill;Monolayer Experiments;Immune Checkpoint;Drug Sensitive Cell Line;PDAC Cell;Multiple Cancer Types;Drug Delivery;ABM;Pancreatic Cancer;Normalize AUC;Immune Cell Killing;Immune Checkpoint Inhibitors;Mass Transport Properties;Immunotherapy Modeling;Free DOX;Delta Measurement;Immune Cell Recruitment;Mathematical Pathology;Non-muscle Invasive Bladder Cancer
